-

About This Paid Research Study

This research study is testing trevogrumab, garetosmab, and Wegovy® (semaglutide) either alone or in different combinations with each other. The goal of the research study is to see how safe and effective the study medication is when combined with Wegovy® (semaglutide) in overweight or obese patients. Some participants will receive the study medication + Wegovy® (semaglutide), while others will receive a placebo + Wegovy® (semaglutide).  (A placebo looks like the study medication but does not contain any active ingredients.) 

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

You May Qualify If You:

• Are between 18 and 80 years old

• Are currently overweight or obese

• Are not diabetic

Have had at least 1 unsuccessful attempt at losing weight from dieting

Study Details

Up to 20 months

Up to $6,950

Sign Up Today!

To join this paid research study, you will need to complete an easy and risk-free, 20-minute phone questionnaire about you and your current health status. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling research studies at our research center.